1 Min Read
May 10 (Reuters) - Heron Therapeutics Inc:
* Heron Therapeutics reports financial results for the three months ended March 31, 2017 and recent corporate progress
* Quarterly loss per share $1.00 Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.